iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
66 hedge funds and large institutions have $36.1M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
Holders
66
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.11M | |
| 2 | +$423K | |
| 3 | +$407K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$314K |
| 5 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
+$285K |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$2.76M | |
| 3 | -$924K | |
| 4 |
Morgan Stanley
New York
|
-$793K |
| 5 |
MFA
Mayflower Financial Advisors
Boston,
Massachusetts
|
-$648K |